Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karin U. Travers is active.

Publication


Featured researches published by Karin U. Travers.


The Journal of Infectious Diseases | 1999

Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV-1 and HIV-2

Stephen J. Popper; Abdoulaye Dieng Sarr; Karin U. Travers; Aissatou Guèye-Ndiaye; Souleymane Mboup; Myron Essex; Phyllis J. Kanki

Human immunodeficiency virus type 2 (HIV-2) is less pathogenic than HIV type 1 (HIV-1), but the mechanisms underlying this difference have not been defined. We developed an internally controlled quantitative reverse transcriptase-polymerase chain reaction to measure HIV-2 viral load and determined levels of plasma virus in a cohort of registered commercial sex workers in Dakar, Senegal. The assay has a lower limit of detection of 100 copies/mL and is linear over 4 logs. HIV-2 viral RNA was detectable in 56% of all samples tested; the median load was 141 copies/mL. Levels of viral RNA in the plasma were inversely related to CD4+ cell counts. HIV-2 and HIV-1 viral loads were compared among the seroincident women in the cohort; the median viral load was 30x lower in the HIV-2-infected women (P<.001, Wilcoxon rank sum test), irrespective of the length of time infected. This suggests that plasma viremia is linked to the differences in the pathogenicity of the 2 viruses.


Cancer Investigation | 1996

Clusters of Lymphoma in Ferrets

Susan E. Erdman; Phyllis J. Kanki; Frances M. Moore; Susan A. Brown; Thomas A. Kawasaki; Keith W. Mikule; Karin U. Travers; Steven F. Badylak; James G. Fox

Cluster outbreaks of lymphoma and leukemia have been associated with viral infections in many species including humans, cattle, and cats. This study describes epidemiological, clinical, and pathological features of cluster outbreaks of lymphoma in multiferret households and examines and compares the Aleutian disease virus (ADV) and feline leukemia virus (FeLV) status of cases, ferrets at risk, and controls. Three ferret groups with 21 cases of histologically diagnosed lymphoma (12.6% cumulative incidence) and their cohabitants (n = 35) were examined and compared with three control groups (n = 52) of cohabitating ferrets without lymphoma. A familial distribution was observed in one group but most cases were not consanguinous. Ferrets greater than 3 years of age developed chronic disease in two of the groups and 2-year-old adults had acute disease in the remaining group. Lymphocytosis, splenomegaly, and lymphadenopathy were prominent features. Histologically, predominantly small noncleaved cell and polymorphous lymphoid lesions were observed. All of the ferrets with lymphoma that were tested for ADV and FeLV using serology or PCR were negative. The rate of ADV antibody among cases or ferrets at risk was not significantly different from controls. None of the cluster ferrets were seropositive for FeLV p27 antigen using a monoclonal ELISA. Infection with a novel ferret virus is suspected, but an etiological agent has not yet been identified.


Archive | 1990

HIV Antibody Detection in Serum

Karin U. Travers; Phyllis J. Kanki

Acquired immunodeficiency syndrome (AIDS) is caused by a human retrovirus termed human immunodeficiency virus (HIV). HIV infection is now recognized worldwide and represents a major public health problem. Antibodies raised against HIV in a patient’s serum provide the most common methods of determination of HIV exposure. Concern regarding the accuracy and the proper use of serologic tests for HIV antibodies in serum has been alleviated by data that have shown a variety of serologic tests to now be accurate [1], and useful both as diagnostic tools [2], and as research tools [3].


Science | 1994

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

Richard Marlink; Phyllis J. Kanki; Ibou Thior; Karin U. Travers; Geoffrey Eisen; T. Siby; Ibrahima Traoré; Hsieh Cc; Mamadou C. Dia; Eh Gueye


The Lancet | 1994

Slower heterosexual spread of HIV-2 than HIV-1

Phyllis J. Kanki; Karin U. Travers; Richard Marlink; Max Essex; S. M'Boup; Guèye-Ndiaye A; T. Siby; Ibou Thior; J-L. Sankalé; Hsieh Cc; M. Hernandez-Avila; Ibra Ndoye


Science | 1995

Natural protection against HIV-1 infection provided by HIV-2

Karin U. Travers; S. M'Boup; Richard Marlink; A Gueye-Nidaye; T. Siby; Ibou Thior; Ibrahima Traoré; A Dieng-Sarr; Jean Louis Sankalé; C Mullins


American Journal of Epidemiology | 1992

Prevalence and Risk Determinants of Human Immunodeficiency Virus Type 2 (HIV-2) and Human Immunodeficiency Virus Type 1 (HIV-1) in West African Female Prostitutes

Phyllis J. Kanki; S. M'Boup; Richard Marlink; Karin U. Travers; Hsieh Cc; Guèye A; Cheikh Saad Bouh Boye; Jean Louis Sankalé; Christl Donnelly; Wendy Leisenring; T. Siby; Ibou Thior; Mamadou C. Dia; Eh Gueye; Ibra Ndoye; Max Essex


Science | 1987

Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

Phyllis J. Kanki; S. M'Boup; D Ricard; Francis Barin; François Denis; Cheikh Saad Bouh Boye; Sangaré L; Karin U. Travers; M Albaum; Richard Marlink


AIDS | 1998

Protection from HIV-1 infection by HIV-2.

Karin U. Travers; Geoffrey Eisen; Richard Marlink; Max Essex; Hsieh Cc; Mboup S; Phyllis J. Kanki


Virology | 2000

Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype.

Abdoulaye Dieng Sarr; Jean-Louis Sankalé; Donald J. Hamel; Karin U. Travers; Aissatou Guèye-Ndiaye; Max Essex; Souleymane Mboup; Phyllis J. Kanki

Collaboration


Dive into the Karin U. Travers's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Souleymane Mboup

Cheikh Anta Diop University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge